29.07.2015 • News

Solvay Starts Fluoroelastomers Plant in China

pavalena - Fotolia
pavalena - Fotolia

As part of the ongoing strategic expansion of its site at Changshu in China’s Jiangsu Province Solvay Specialty Polymers has started up a new fluoroelastomers (FKM) plant. The Belgian chemical producer said the new capacity will meet demand for the specialty polymers from Asia’s fast-growing automotive industry and multiple other high-end markets.

Solvay said its global business unit’s third production plant worldwide for the fluorelastomer unit sold under the Tecnoflon brand name will benefit from the site’s existing Specialty Polymers operations and infrastructure, as well as from secure raw material supplies through its  joint venture with nearby Shanghai 3F New Materials Co., Ltd.

“This state-of-art fluoroelastomers facility considerably strengthens our global industrial footprint, extending our reach from Europe and the United States to Asia,” said Augusto Di Donfrancesco, president of Solvay’s Specialty Polymers.

At the same site, the polymers subsidiary is building  plant to produce polyvinylidene fluoride (PVDF),  due to go on-stream early 2017. In addition to fluoroelastomers, Solvay’s operations at Changshu include compounding, based on its specialty polymers resins.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read